WO2003078023A1 - Compound removal device - Google Patents
Compound removal device Download PDFInfo
- Publication number
- WO2003078023A1 WO2003078023A1 PCT/US2003/006922 US0306922W WO03078023A1 WO 2003078023 A1 WO2003078023 A1 WO 2003078023A1 US 0306922 W US0306922 W US 0306922W WO 03078023 A1 WO03078023 A1 WO 03078023A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particles
- support surface
- support
- sheet
- sorptive
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 72
- 239000011324 bead Substances 0.000 claims abstract description 33
- 239000002245 particle Substances 0.000 claims description 98
- 239000000853 adhesive Substances 0.000 claims description 45
- 230000001070 adhesive effect Effects 0.000 claims description 45
- 239000000463 material Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 11
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 9
- 230000001681 protective effect Effects 0.000 claims description 8
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 239000012943 hotmelt Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000002594 sorbent Substances 0.000 abstract description 58
- 239000013060 biological fluid Substances 0.000 abstract description 45
- 244000052769 pathogen Species 0.000 description 34
- 230000001717 pathogenic effect Effects 0.000 description 32
- 230000002779 inactivation Effects 0.000 description 26
- 238000011282 treatment Methods 0.000 description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000003463 adsorbent Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 229920003023 plastic Polymers 0.000 description 10
- 239000004033 plastic Substances 0.000 description 10
- 239000010410 layer Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical group ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000005245 sintering Methods 0.000 description 3
- -1 2- [bis(2 chloroethyl) amino] ethyl Chemical group 0.000 description 2
- ADHFMENDOUEJRK-UHFFFAOYSA-N 9-[(4-fluorophenyl)methyl]-n-hydroxypyrido[3,4-b]indole-3-carboxamide Chemical compound C1=NC(C(=O)NO)=CC(C2=CC=CC=C22)=C1N2CC1=CC=C(F)C=C1 ADHFMENDOUEJRK-UHFFFAOYSA-N 0.000 description 2
- 241001482237 Pica Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002186 photoactivation Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000004559 acridin-9-yl group Chemical group C1=CC=CC2=NC3=CC=CC=C3C(=C12)* 0.000 description 1
- 125000000641 acridinyl group Chemical class C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 150000004780 naphthols Chemical class 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 229920001862 ultra low molecular weight polyethylene Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28026—Particles within, immobilised, dispersed, entrapped in or on a matrix, e.g. a resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1487—Inlet or outlet ports with friction fit, e.g. connecting tubes directly to a protruding port
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
- A61M1/3686—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents by removing photoactive agents after irradiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/261—Synthetic macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/2805—Sorbents inside a permeable or porous casing, e.g. inside a container, bag or membrane
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/321—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3223—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating by means of an adhesive agent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3234—Inorganic material layers
- B01J20/324—Inorganic material layers containing free carbon, e.g. activated carbon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/327—Polymers obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3276—Copolymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
- B01J20/3282—Crosslinked polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
Definitions
- the present invention relates to devices for removing compounds from a fluid, such as blood or other biological fluid.
- the present invention also relates to methods for making such devices .
- Removal devices include an adsorptive or absorbtive material (“sorbent”) that removes or binds the selected compound.
- sorbent an adsorptive or absorbtive material
- the sorbent is often combined or carried by a support and/or placed inside a container or a housing. Removal devices may be a "batch- type” or "flow through” device.
- the biological fluid that has been treated in a pathogen inactivation treatment remains in contact with the sorbent for a pre-determined period of time.
- the container with the biological fluid and the removal device may be agitated to maximize exposure of the biological fluid to the sorbent of the removal device.
- the removal device is typically placed in the line of flow of the biological fluid.
- the sorbent may be contained in a housing that has an inlet port and outlet port.
- a container containing a biological fluid with the pathogen inactivation compound or a derivative may be attached, by plastic tubing, to the inlet port.
- Another container for receiving the biological fluid may be likewise attached to the outlet port of the housing. As fluid flows from one container to the other, it contacts the sorbent of the removal device. Thus, compounds are removed, and a substantially compound-free biological fluid is collected in the receiving container.
- the removal device consists of a porous membrane containing an adsorbent in the form of a powder or fine particles combined with a polymeric material such as polyurethane to form the porous membrane.
- the membrane is fixed on a support having a net structure.
- the "absorber" membrane and support
- the "absorber” may be rolled or superposed into multiple layers and then housed in a vessel having an inlet and an outlet for the blood to provide a flow-through device. Similar flow-through devices using activated charcoal are described in U.S. Patent Nos. 5,660,731 and 5,639,376.
- the batch-type device described in U.S. Patent Application Serial No. 09/112,400 can be formed in one of many different ways.
- synthetic, microporous sorbent particles are immobilized within an inert matrix by, for example, combining the sorbent particles with a binding material and sintering the combination to form an adsorbent wafer.
- the sintered wafer has sorbent particles in the wafer interior and on the wafer surface to maximize contact of the biological fluid with the sorbent particles.
- the wafer may be placed inside a mesh pouch or other liquid permeable enclosure to ensure that any loose particulate from the wafer does not pass into the biological fluid.
- the beads are packed in a column having an inlet and an outlet for introducing and removing the biological fluid.
- the sorbent beads may be finely ground and then combined with the binding material to form a wafer. The wafer is placed inside a flow-through housing.
- the removal device includes activated charcoal or synthetic beads as the sorbent particulate, one potential concern with such devices is particle shedding. Thus, it would be desirable to provide a compound removal device where shedding of particulate is minimized.
- Another potential drawback with some of the existing compound removal devices is the cost of manufacture.
- a removal device that requires, for example, many beads (due to, for example, low surface area contact of the beads with the biological fluid) may increase the cost of making a compound removal device. Furthermore, additional steps such as sintering the sorbent particles with the polymeric material may also increase the cost.
- the present invention is directed to a device for removing a compound from a fluid.
- the device includes at least one support surface and a plurality of sorbent particles carried by said support surface.
- the particles on said support surface have a masked area wherein the particles contact the support surface and an unmasked area not in contact with the support surface .
- the present invention is directed to a sorbent core for use with a compound removal device.
- the core includes a plurality of layers, wherein each layer comprises a sheet having first and second sides with a plurality of sorbent particles attached to at least one of the sides to provide alternating portions of the sheets and particles.
- the sorbent core may be associated with inlet and outlet ports to provide a flow-through compound removal device.
- the present invention is directed to a method of making a device for removing a compound from a fluid.
- the method includes providing a flexible support sheet having first and second oppositely facing sides wherein at least one of the sides comprises an adhesive surface.
- the method further includes applying a plurality of sorbent particles to the adhesive surface.
- Figure 1 is a plan view of a plastic container for holding a biological fluid and including a removal device embodying the present invention
- Figure 2 is a plan view of a removal device embodying the present invention housed inside a mesh or other liquid permeable pouch;
- Figure 3 is a perspective view of a removal device embodying the present invention.
- Figure 4 is a plan view of a support for use in the present invention, having adhesive surfaces and protective backing films thereon;
- Figure 5 shows a disc-shaped compound removal device embodying the present invention
- Figure 6 is a side view of the removal device of Figure 5 ;
- Figure 7 is a plan view of a biological fluid processing set including containers and a flow-through removal device embodying the present invention
- Figure 8 is a plan view of a flow-through removal device embodying the present invention.
- Figure 9 is a cross-sectional view of the removal device of Figure 8.
- Figure 10 is a side view of a support sheet with sorbent particles applied thereon;
- Figure 11 is a plan view of the sheet of Figure 10 rolled onto itself to provide a cylindrical compound removal device or core;
- Figure 12 is a perspective view of the core of Figure 11 sliced into a plurality of disc-shaped removal devices;
- Figure 13 is a plan view of a portion of a method of making the removal device embodying the present invention
- Figure 14 is a perspective view of an alternative method of making a removal device embodying the present invention.
- Figure 15 is a general diagram showing a continuous manuf cturing line for making removal devices embodying the present invention.
- Figure 16 is a composite diagram showing some of the different steps in the manufacture of a removal device embodying the present invention.
- Figure 17 is a photograph, (taken by a scanning electron microscope and magnified 50x) of the top surface of a removal device embodying the present invention
- Figure 18 is a photograph, (taken by a scanning electron microscope and magnified 25x) providing a side view of a removal device embodying the present invention
- Figure 19 is a photograph, (taken by a scanning electron microscope and magnified 5Ox) proving a side view of a removal device embodying the present invention
- Figure 20 is another photograph (taken by a scanning electron microscope and magnified 3Ox) of a removal device embodying the present invention with beads on one surface of the device support being pulled away from the surface; and
- Figure 21 is a photograph, (taken by a scanning electron microscope and magnified 25x) of a removal device embodying the present invention with the beads on one surface of the device support being pulled away from the surface.
- the removal devices of the present invention are particularly well suited for use in the treatment of biological fluids, such as blood.
- the removal devices of the present invention are useful in removing compounds from a biological fluid such as blood that has been contacted with the chemical compound in the course of a pathogen inactivation treatment. Accordingly, the present invention is described below in the context of removing pathogen inactivation compounds and/or their derivatives from biological fluids. However, it will be understood that the devices of the present invention may also have uses in other fields where removal of a selected compound from a fluid is desired.
- the biological fluid to be treated is combined with a pathogen inactivation compound.
- the compound can be a photoactivation agent that, when contacted with light, acts on the pathogen, or may be a compound that directly acts on the pathogen without any such external stimulus .
- the compound acts by crosslinking the DNA and/or RNA of the pathogen, thereby inactivating it and preventing the pathogen from replicating.
- photoactivation agents and/or pathogen inactivation agents include the families of psoralens and acridines .
- a compound used in light activated pathogen inactivation is 5'- (4-amino-2-oxa) butyl-4, 5', 8- trimethyl psoralen. Details of such pathogen inactivation compounds and treatments are described in U.S. Patent Nos. 5,691,132, 5,593,823 and 6,190,609, all of which are incorporated herein by reference .
- pathogen inactivation compounds include phthalocyanine derivatives, phenothiazine derivatives (including methylene blue or dimethyl-methylene blue) ; endogenous and exogeneous photosensitizers such as alloxazines, isoalloxazines (including riboflavin) , vitamin Ks, vitamin L, na ththoquinones, naphthalenes, naphthols and other compounds disclosed in United States Patent Nos . 6,258,577, 6,268,120 and 6,277,337 which are also incorporated by reference, or "Pen 110" which is made by V.I. Technologies, Inc. (and is also known by its trade name, the InactineTM compound) .
- the above described compounds are particularly useful in the inactivation of blood platelets and plasma.
- pathogen inactivation compounds include some of the compounds disclosed above and in U.S. Patent No. 6,093,725 and U.S. Application Serial No. 09/539,226 filed March 30, 2000, incorporated herein by reference, which disclose compounds having nucleic acid affinity and containing a mustard group, mustard group equivalent or mustard group intermediate.
- a preferred compound for red blood cell pathogen inactivation is p-alanine, N- (acridin-9-yl) , 2- [bis(2 chloroethyl) amino] ethyl ester.
- Figure 1 shows a container 10 for holding blood that has been subjected to a pathogen inactivation treatment and that may include unreacted compounds and/or derivatives thereof .
- Container 10 includes a removal device 20 disposed within container 10 to provide a "batch-type" compound removal system. In a batch-type system, removal device 20 may preferably be placed within a mesh pouch 25 shown in Figure 1 or other liquid permeable pouch.
- Container 10 may be part of a larger, disposable blood processing set that includes a first container for holding the biological fluid during the pathogen inactivation treatment, container 10 and a final storage container for receiving the fluid after contact with the compound removal device and for storing the fluid.
- the processing set may be comprised of the first container and container 10 which holds the removal device and also serves as the final storage container.
- the processing set may also include a container that holds the pathogen inactivation agent. All of the containers may be integrally connected by plastic tubing. Examples of such blood processing sets are provided in U.S. Patent Application Serial No. 09/325,599, which is incorporated herein by reference in its entirety.
- the walls of container 10 are made of a thermoplastic material suitable for holding and storing biological fluids and sterilizable by one or more known sterilizing methods such as autoclaving, electron beam and gamma-ray radiation.
- a thermoplastic material suitable for holding and storing biological fluids and sterilizable by one or more known sterilizing methods such as autoclaving, electron beam and gamma-ray radiation.
- materials include, but are not limited to, polyvinyl chloride plasticized with one or more plasticizers .
- container 10 is made of a material that includes polyvinyl chloride plasticized with di- ethylhexylphthalate ester and epoxydized oil . Containers made of such material are useful for storing blood platelets and plasma, and are commercially available from Baxter Healthcare Corporation of Deerfield, Illinois under the product code PL-1813.
- Container 10 may also be made from a plastic material that is a blend of ethylene-vinyl acetate, ultra low density polyethylene and a block copolymer, such as a SEBS-type block copolymer.
- Plastic containers of this type are particularly well suited for storing blood platelets and are, likewise, available from Baxter Healthcare Corporation of Deerfield, Illinois under product code PL-2410.
- Container 10 can include a plastic tube 12 that provides a flow path for introducing a biological fluid from another attached container (not shown) and/or removing the fluid from container 10.
- removal device 20 includes a generally flat support 24.
- Support 24 may be a solid support, or more preferably, a thin, flexible sheet of a biologically compatible polymeric material, described in more detail below.
- Figure 4 shows a preferred support for manufacture of a removal device of the present invention.
- support 24 is a flat sheet made of polymeric material such as a non-woven polymeric material.
- the oppositely facing surfaces 26 and 28 of sheet 24 include a pressure sensitive adhesive or other type of adhesive substance. Alternatively, only one of the surfaces 26 may be coated with adhesive.
- support 24 may be provided with protective backing films 29 and 30 to protect the adhesive prior to use and prior to coating with the sorbent particles. Protective backing films 29 and 30 are peeled off as generally shown in Figure 4, just prior to application of the sorbent beads .
- the adhesive used may be any adhesive that is biocompatible with blood and blood products or other biological fluids.
- the adhesive should be one that will not leach into the biological fluid and has sufficient tackiness to substantially retain the adsorbent particles on the surface thereof .
- the compound removal device of the present invention includes an adhesive coated support sheet made from a polyester, such as Mylar ® , or a spun-laced polyester, coated with a biocompatible adhesive such as, but not limited to, a hypoallergenic acrylate adhesive.
- Support sheet 24 may have any thickness required or desired, although a relatively thin support is preferred because it allows for better fluid movement of the biological fluid over and around the device, thereby allowing for more complete contact with the biological fluid.
- the preferred thickness of the support sheet can be between 1 to 10 mils.
- the sheets may be provided as individual sheets or, more preferably, provided from a roll of material from which individual sheets can be prepared. Adhesive coated sheets or tapes suitable for use in the present invention will be known to those of skill in the art and are available from the 3M Company of St. Paul, Minnesota, Avery Dennison Corporation of Pasadena, California, and other manufacturers.
- support sheet 24 is coated with a plurality of sorbent beads or particles 22.
- sorbent particles 22 are applied to support 24 as a single layer. The particles may be manually applied to the adhesive surface, uniformly distributed and compressed to secure the particles to the adhesive surface. Loose, excess particles may be removed (e.g., by shaking the support sheet) . More automated methods for making the compound removal device are described below.
- sorbent is meant to include a material that removes compounds either by adsorption or absorption.
- Adsorbent particles suitable for use in the compound removal device of the present invention can be any particulate that does not substantially adversely affect the biological activity of a biological composition upon contact.
- the adsorbent particle can, for example, be made of materials such as activated carbon, hydrophobic resins, hydrophilic resins or ion exchange resins.
- the adsorbent particles are activated carbons derived either from natural or synthetic sources .
- the activated carbons are derived from synthetic sources.
- Non-limiting examples of activated carbons include Picactif Medicinal ® , which is available from PICA USA Inc.
- the particles can be hydrophobic resins.
- Non-limiting examples of hydrophobic resins include the following polyaromatic adsorbents: Amberlite ® adsorbents (e.g., Amberlite ® XAD-2, XAD-4, and XAD-16) , available from Rohm and Haas (Philadelphia, PA) ; Amberchrom ® adsorbents available from Toso Haas (Toso Hass, Montgomeryville, PA); Diaion ® //Sepabeads ® Adsorbents (e.g., Diaion ® HP20) , available from Mitsubishi Chemical America, Inc.
- Amberlite ® adsorbents e.g., Amberlite ® XAD-2, XAD-4, and XAD-16
- Rohm and Haas Philadelphia, PA
- Amberchrom ® adsorbents available from Toso Haas (Toso Hass, Montgomeryville, PA)
- examples of particularly preferred beads are Dowex ® XUS-43493 and Purolite ® MN-200 or MN-250, identified above.
- Removal device 20 may be cut or otherwise provided in any shape desired. As shown in Figs. 1-2, removal device may have a .generally rectangular shape, having a width almost equal to the width of container 10. As shown in Figs. 5 and 6, removal device may also be provided as a disc with sorbent particles 22 applied to one or both surfaces 26 and 28 of the disc.
- support 24 with sorbent particles 22 carried thereon may be enclosed and sealed inside a liquid permeable pouch 25.
- Liquid permeable pouch 25 provides an additional protective barrier in the event that the sorbent particles 22 become detached from the support.
- Mesh pouch 25 may be made of any suitable material, with polyester and nylon being preferred. Materials suitable for use as mesh pouches are available from Tetko of Briarcliff Manor, New York, and sold under the product designation Medifab 07-30-21.
- the mesh enclosure may be radio frequency sealed around the compound removal device or directly to outer edges of the compound removal device.
- the compound removal device of the present invention may include a plurality of layers to provide either a batch-type device or, more preferably, a flow-through device.
- removal device 20 may include alternating layers of support 24 and sorbent particles 22.
- a layered removal device provides a core for a flow-through device .
- Figures 7-10 show an embodiment of the removal device 50 wherein an inner core 40 is made of a plurality of layers of alternating support sheet 24 and sorbent particles 22.
- the removal device 50 and, more particularly, core 40 shown in Figure 7-10 is particularly well suited for use in a flow-through system.
- removal device 50 has an inlet 52 and outlet 54. Inlet 52 and outlet 54 are attached to plastic tubes 56 and 58 that provide flow paths to and from containers 60 and 62 of a blood bag system.
- container 60 which may hold the biological fluid that has been treated in a pathogen inactivation treatment and may include unreacted pathogen inactivation compound and/or derivatives thereof, is attached to the inlet port 52 of the compound removal device 50 via plastic tube 56.
- the outlet port 54 is attached to plastic tube 58 that provides a flow path to a collection container 62 for receiving the biological fluid substantially free of the pathogen inactivation compound or any byproducts.
- Removal device 50 includes an inner core 40 provided as a plurality of alternating layers of support sheet 24 and sorbent particles 22.
- the core 40 may be provided by taking a sheet 24 of the type shown in Figure 10 and rolling sheet 24 onto itself to provide a "jellyroll" type core 40, as shown in Figure 11.
- the core 40 may be enclosed in a suitable housing 50 made of a lightweight, biocompatible material, that will be known to those skilled in the art.
- biological fluid enters device 50 through inlet 52. As it passes through device 50, the fluid contacts the sorbent particles 22 of the core 40. Sorbent particles 22 remove the desired compounds from the fluid stream, resulting in a biological fluid substantially free of the compounds.
- the biological fluid exits through outlet 54 and is collected in container 62.
- the rate of flow of fluid and the residence time of fluid in contact with particles 22 can be controlled, in part, by how tightly the core has been wound.
- FIG. 11 For example, using the "jellyroll" core shown in Figure 11, smaller disks 72 of a removal can also be provided. As shown for example in Figure 12, the core 40 can be sliced to provide a plurality of compound removal disks 72. Disks 72 can further be enclosed in a mesh pouch and placed inside a plastic container for holding biological fluid in a batch-type system.
- sorbent particles or beads may be placed on a sheet of liquid permeable mesh material 27. Interspersed with the sorbent particles or beads 22 are larger particles 23 of hot melt or other similar adhesive. As shown in Figure 14, the particles of hot melt adhesive are generally larger than the maximum diameter of the largest bead 22. A second layer of the liquid permeable mesh material 27 is then placed over the bed of absorbent and adhesive beads. The two sheets of liquid permeable mesh with sorbent and adhesive beads between them are then passed through a heating and compressing element such as heated rolls 25.
- a heating and compressing element such as heated rolls 25.
- the gap between the sheet layers is smaller than the smallest of the meltable/fusible adhesive particles but larger or equal to the maximum diameter of the largest sorbent particles.
- the resulting structure provides two sheets fused to each other through the molten/fused adhesive hot melt particles, thereby immobilizing the smaller particles between them as shown in Figure 14.
- meltable/fusible adhesive particles instead of using meltable/fusible adhesive particles, a meltable/fusible fiber strip or any other shaped adhesive material may also be used.
- the edges of the structure can be sealed by means known in the art and also by making the extreme outside edges of the meltable/fusible entities elongated and continuous along the structure .
- the compound removal devices of the present invention provide lightweight and easy to manufacture alternatives to currently known removal devices.
- the removal devices described above provide efficiencies and economies in manufacturing in that they do not require the sintering or other more complex manufacturing steps .
- Removal devices of the present invention also maximize exposure of the surface area of the sorbent particles to the biological fluid to be contacted.
- Removal devices made in accordance with the present invention provide the ability to adsorb/absorb compounds (e.g., pathogen inactivation compounds) as well or better than known removal devices that use significantly more sorbent beads.
- removal devices made in accordance with the present invention provide excellent adhesion between the support 24 and sorbent particles 22, thus minimizing the chance of particle shedding.
- Figures 17-21 are photographs of the surfaces (26 or 28) and sides of the removal device (of the type shown in Figures 1-3) taken with a scanning electron microscope. Figures 17-21 show some of the unique and superior properties of the removal device. As shown in these Figures, the sorbent particles of the present invention provide a large surface area for exposure of the sorbent to the biological fluid to be contacted.
- Figure 17 shows the surface (26 or 28) of a flat sheet removal device made in accordance with a present invention. Because the sorbent particles are attached to the support sheet at the adhesive surface only, there is no adhesive material masking most of the particle surface.
- Figures 18 and 19 are side views of a flat sheet compound removal device made in accordance with a present invention, using a flat sheet support, with an adhesive support, and a (single) layer of sorbent particles applied thereon.
- adhesion of the sorbent particles to the flat sheet support is shown.
- the sorbent particles are attached to the flat sheet support, and more particularly, to the adhesive material on the surface of the flat sheet, in such a way that only a small area of the particles surface is masked from contact with the biological fluid.
- the "unmasked" area of the sorbent particles is substantially greater than the "masked" area where the particle is attached to the adhesive surface of the support sheet .
- the removal device of the present invention includes a uniform and single layer of sorbent particles on the device surface. Thus, all the particles are substantially exposed to the biological fluid, and none of the particles are buried in the interior of the device where contact with the biological fluid is less direct.
- the biological fluid compound removal devices of the present invention are less likely to shed or otherwise lose sorbent particles which can then enter the biological fluid.
- the strong adhesion between the particles and adhesive on the surface of the support sheet is such that the particles do not become easily dislodged from the support sheet surface.
- the strong adhesion of the particles to the support surface is demonstrated and shown in Figures 20-21. Particles adhered to a support surface with pressure sensitive adhesive were contacted at their exposed (unmasked) surfaces with another portion of the adhesive surface. The two surfaces were then pulled apart, so that the beads were pulled away from the support sheet.
- compound removal devices of the present invention provide advantages over currently known removal devices. First, they provide a removal device wherein the "unmasked" area of the sorbent particles is substantially greater than the "masked" area where the particle contacts the surface. However, even with such minimal contact between the adhesive of the support sheet and the particles surface, the removal device of the present invention does not substantially shed particles. The ability of the compound removal device to retain most of the particles without shedding is further demonstrated by the following examples .
- Removal devices in accordance with the present invention may be made individually or, more preferably, as part of a continuous process.
- Figure 15 is a diagram of a continuous process for manufacturing removal devices of the present invention.
- Figure 16 is a composite view illustrating some of the different steps shown diagrammatically in Figure 15.
- a dispensable roll 100 of the double-sided adhesive tape 102 of the type described above may be provided.
- the paper is threaded over rollers 112 which advance the tape 102 through a series of processing steps.
- the double-sided adhesive tape 102 may be pre-scored and pre-perforated for removal of selected portions of the protective backing film, as described in more detail below and shown, for example, by the broken lines in tape 102 in Figure 16.
- pickup mechanism 114 removes a portion of the pre-scored backing film (29 and/or 30) as the belt moves through the system, thereby exposing central portions of both sides (or if desired, one side) of the adhesive surface 26 of tape 102.
- the paper may be pre- scored in such a way that only a film "frame" 138 remains on the tape 102.
- Tape 102 is advanced to a reservoir 116 containing suitable particles or beads .
- the exposed portions of adhesive surfaces 26 and 28 are coated with and covered by the particulate or beads 22 in the reservoir 116.
- the portion of the belt exits the reservoir it has a bead 22 or other particulate coating on both surfaces 26 and 28 of the tape 102.
- FIG. 13 depicts one example of a reservoir 116 that can be used in the manufacturing line shown in Figures 15 and 16.
- Reservoir 116 may be generally V-shaped having a narrow inlet slit 140 through which adhesive tape 102 enters the reservoir. Once coated with beads 22 or other particulate, tape 102 exit through the wide mouth 142 of the reservoir.
- rollers 112 advance tape 102 through the system whereby bead coated surfaces 26 and 28 are contacted with brushes 118. Brushes 118 remove excess loose beads or particulate from the tape 102.
- the bead-coated tape 102 moves through a set of rollers 122 that compress the beads onto the adhesive.
- the remaining frame is removed by paper pickup device 124, thus removing the "frame" 138 of backing film, and providing and exposing an "adhesive coated frame" 142 around the bead-coated surfaces 24 and 26 of the tape 102.
- sheets of mesh 144 can be applied over both surfaces of the removal device.
- sheets of mesh 144 can be applied from dispensing rollers 130 over each of the bead-coated surfaces 24 and 26.
- the bead- coated removal device, sandwiched between two sheets of the mesh enclosure, may now be sealed by radio' frequency or other known sealing techniques, depicted generally at 146 so as to completely enclose the removal device within the mesh pouch.
- the mesh sheets may adhere directly to the adhesive coated frame 142, with or without additional sealing.
- tape 102 may be cut along the seal line to the desired size at the end of the process to provide a removal device.
- the removal device is to be used as a core 40 in a flow-through device 50
- the bead- coated tape prepared in the manner described above can be "jelly-rolled" and placed in a housing 50 as shown and described above.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003213758A AU2003213758A1 (en) | 2002-03-14 | 2003-03-06 | Compound removal device |
JP2003576074A JP2005519744A (en) | 2002-03-14 | 2003-03-06 | Compound remover |
EP03711447A EP1487559A4 (en) | 2002-03-14 | 2003-03-06 | Compound removal device |
CA002477946A CA2477946A1 (en) | 2002-03-14 | 2003-03-06 | Compound removal device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36428902P | 2002-03-14 | 2002-03-14 | |
US60/364,289 | 2002-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003078023A1 true WO2003078023A1 (en) | 2003-09-25 |
Family
ID=28041897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/006922 WO2003078023A1 (en) | 2002-03-14 | 2003-03-06 | Compound removal device |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1487559A4 (en) |
JP (1) | JP2005519744A (en) |
AU (1) | AU2003213758A1 (en) |
CA (1) | CA2477946A1 (en) |
WO (1) | WO2003078023A1 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2501419B1 (en) * | 2009-11-17 | 2015-06-03 | Brightwake Limited | Device for processing fluid |
WO2016014854A1 (en) | 2014-07-23 | 2016-01-28 | Cerus Corporation | Methods for preparing platelet products |
WO2016057965A1 (en) | 2014-10-10 | 2016-04-14 | Cerus Corporation | Compositions and methods for treating viral hemorrhagic fever |
WO2016210374A1 (en) | 2015-06-26 | 2016-12-29 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
WO2017070619A1 (en) | 2015-10-23 | 2017-04-27 | Cerus Corporation | Plasma compositions and methods of use thereof |
WO2017120545A2 (en) | 2016-01-07 | 2017-07-13 | Cerus Corporation | Systems and methods for preparation of platelets |
EP2665358B1 (en) * | 2011-01-06 | 2018-08-29 | Cytosorbents Corporation | Polymeric sorbent for removal of impurities from whole blood and blood products |
WO2018161020A1 (en) | 2017-03-03 | 2018-09-07 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
WO2019060610A1 (en) | 2017-09-20 | 2019-03-28 | Cerus Corporation | Compositions and methods for pathogen inactivation of platelets |
WO2019133929A1 (en) | 2017-12-29 | 2019-07-04 | Cerus Corporation | Systems and methods for treating biological fluids |
WO2020061537A1 (en) | 2018-09-20 | 2020-03-26 | Cerus Corporation | Methods and kits for preparing pathogen-inactivated whole blood |
US10639413B2 (en) | 2013-06-24 | 2020-05-05 | Exthera Medical Corporation | Blood filtration system containing mannose coated substrate |
US10688239B2 (en) | 2005-12-13 | 2020-06-23 | Exthera Medical Corporation | Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
US10786615B2 (en) | 2016-03-02 | 2020-09-29 | Exthera Medical Corporation | Method for treating drug intoxication |
US10822461B2 (en) | 2017-10-05 | 2020-11-03 | Fresenius Medical Care Holdings, Inc. | Polysulfone-urethane copolymer, membranes and products incorporating same, and methods for making and using same |
US10857283B2 (en) | 2014-09-22 | 2020-12-08 | Exthera Medical Corporation | Wearable hemoperfusion device |
US11123466B2 (en) | 2009-12-01 | 2021-09-21 | Exthera Medical Corporation | Methods for removing cytokines from blood with surface immobilized polysaccharides |
US11266772B2 (en) | 2012-06-13 | 2022-03-08 | Exthera Medical Corporation | Use of heparin and carbohydrates to treat cancer |
US11306346B2 (en) | 2013-11-08 | 2022-04-19 | Exthera Medical Corporation | Methods for diagnosing infectious diseases using adsorption media |
US11844895B2 (en) | 2014-04-24 | 2023-12-19 | Exthera Medical Corporation | Method for removing bacteria from blood using high flow rate |
US11883544B2 (en) | 2019-06-28 | 2024-01-30 | Cerus Corporation | System and methods for implementing a biological fluid treatment device |
US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
US12011510B2 (en) | 2019-06-22 | 2024-06-18 | Cerus Corporation | Biological fluid treatment systems |
US12090261B2 (en) | 2019-05-16 | 2024-09-17 | Exthera Medical Corporation | Method for modulating endothelial glycocalyx structure |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12089589B2 (en) | 2009-10-12 | 2024-09-17 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
US11284616B2 (en) | 2010-05-05 | 2022-03-29 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
US9199016B2 (en) | 2009-10-12 | 2015-12-01 | New Health Sciences, Inc. | System for extended storage of red blood cells and methods of use |
EP4091645A1 (en) | 2010-08-25 | 2022-11-23 | Hemanext Inc. | Method for enhancing red blood cell quality and survival during storage |
JP5859558B2 (en) | 2010-11-05 | 2016-02-10 | ニュー・ヘルス・サイエンシーズ・インコーポレイテッドNew Health Sciences, Inc. | Erythrocyte irradiation and anaerobic preservation |
US9067004B2 (en) | 2011-03-28 | 2015-06-30 | New Health Sciences, Inc. | Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly |
EP4074395B1 (en) | 2011-08-10 | 2024-01-24 | Hemanext Inc. | Integrated leukocyte, oxygen and/or co2 depletion, and plasma separation filter device |
DK2951552T3 (en) * | 2013-01-31 | 2019-05-20 | Emd Millipore Corp | REQUIREMENT FOR COLLECTION USE |
WO2014134503A1 (en) | 2013-02-28 | 2014-09-04 | New Health Sciences, Inc. | Gas depletion and gas addition devices for blood treatment |
KR102701691B1 (en) | 2015-03-10 | 2024-08-30 | 헤마넥스트 인코포레이티드 | Oxygen reduction disposable kit, device and method of use thereof |
CN107847395B (en) * | 2015-04-23 | 2021-10-15 | 新健康科学股份有限公司 | Anaerobic blood storage container |
BR122021024410B1 (en) | 2015-05-18 | 2022-05-03 | Hemanext Inc | Methods for managing a blood bank and for providing a supply of stored whole blood products for transfusion medicine |
IL303240A (en) | 2016-05-27 | 2023-07-01 | Hemanext Inc | Anaerobic blood storage and pathogen inactivation method |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411948A (en) * | 1979-04-18 | 1983-10-25 | Takeda Chemical Industries, Ltd. | Air filter of three-dimensional mesh-structured webs |
US4551435A (en) * | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
US4728432A (en) | 1982-08-10 | 1988-03-01 | Japan Medical Supply Co., Ltd. | Method for decontaminating blood |
US5124177A (en) * | 1988-05-20 | 1992-06-23 | D-Mark, Inc. | Filter and method of making same |
US5190806A (en) * | 1991-07-04 | 1993-03-02 | W. L. Gore & Associates, Inc. | Liquid-penetration-resistant sorbent laminate |
US5639376A (en) | 1994-01-10 | 1997-06-17 | Hemasure, Inc. | Process for simultaneously removing leukocytes and methylene blue from plasma |
US5660731A (en) | 1994-11-08 | 1997-08-26 | Pall Corporation | Filter for separating photoactive agent |
US6093725A (en) | 1997-01-06 | 2000-07-25 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US6165519A (en) * | 1999-03-19 | 2000-12-26 | Robert Lehrer Associates, Inc. | Filter for adsorption from and/or dispersion of ingredients into a fluid |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
US6277337B1 (en) | 1998-07-21 | 2001-08-21 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0085729B1 (en) * | 1982-02-09 | 1985-11-06 | Nordson Corporation | Process and apparatus for coating a substrate with a highly absorbent material, in particular a hygienic article |
US5500267A (en) * | 1994-08-22 | 1996-03-19 | Canning; George | Slip-resistant mat for absorbing oil and other liquids |
-
2003
- 2003-03-06 WO PCT/US2003/006922 patent/WO2003078023A1/en active Application Filing
- 2003-03-06 EP EP03711447A patent/EP1487559A4/en not_active Withdrawn
- 2003-03-06 CA CA002477946A patent/CA2477946A1/en not_active Abandoned
- 2003-03-06 JP JP2003576074A patent/JP2005519744A/en active Pending
- 2003-03-06 AU AU2003213758A patent/AU2003213758A1/en not_active Abandoned
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411948A (en) * | 1979-04-18 | 1983-10-25 | Takeda Chemical Industries, Ltd. | Air filter of three-dimensional mesh-structured webs |
US4728432A (en) | 1982-08-10 | 1988-03-01 | Japan Medical Supply Co., Ltd. | Method for decontaminating blood |
US4551435A (en) * | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
US5124177A (en) * | 1988-05-20 | 1992-06-23 | D-Mark, Inc. | Filter and method of making same |
US5190806A (en) * | 1991-07-04 | 1993-03-02 | W. L. Gore & Associates, Inc. | Liquid-penetration-resistant sorbent laminate |
US5639376A (en) | 1994-01-10 | 1997-06-17 | Hemasure, Inc. | Process for simultaneously removing leukocytes and methylene blue from plasma |
US5660731A (en) | 1994-11-08 | 1997-08-26 | Pall Corporation | Filter for separating photoactive agent |
US6093725A (en) | 1997-01-06 | 2000-07-25 | Cerus Corporation | Frangible compounds for pathogen inactivation |
US6258577B1 (en) | 1998-07-21 | 2001-07-10 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers |
US6277337B1 (en) | 1998-07-21 | 2001-08-21 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
US6165519A (en) * | 1999-03-19 | 2000-12-26 | Robert Lehrer Associates, Inc. | Filter for adsorption from and/or dispersion of ingredients into a fluid |
US6268120B1 (en) | 1999-10-19 | 2001-07-31 | Gambro, Inc. | Isoalloxazine derivatives to neutralize biological contaminants |
Non-Patent Citations (1)
Title |
---|
See also references of EP1487559A4 |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11065378B2 (en) | 2005-12-13 | 2021-07-20 | Exthera Medical Corporation | Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
US10688239B2 (en) | 2005-12-13 | 2020-06-23 | Exthera Medical Corporation | Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
AU2010320670B2 (en) * | 2009-11-17 | 2015-10-29 | Brightwake Limited | Device and method for processing fluid |
EP2501419B1 (en) * | 2009-11-17 | 2015-06-03 | Brightwake Limited | Device for processing fluid |
US9254354B2 (en) | 2009-11-17 | 2016-02-09 | Brightwake Limited | Device and method for processing fluid |
US11123466B2 (en) | 2009-12-01 | 2021-09-21 | Exthera Medical Corporation | Methods for removing cytokines from blood with surface immobilized polysaccharides |
CN109847403A (en) * | 2011-01-06 | 2019-06-07 | 西托索尔本茨公司 | Polymer absorbant for the removal of impurity from whole blood and blood product |
EP2665358B1 (en) * | 2011-01-06 | 2018-08-29 | Cytosorbents Corporation | Polymeric sorbent for removal of impurities from whole blood and blood products |
US10064406B2 (en) | 2011-01-06 | 2018-09-04 | Cytosorbents Corporation | Polymeric sorbent for removal of impurities from whole blood and blood products |
US11266772B2 (en) | 2012-06-13 | 2022-03-08 | Exthera Medical Corporation | Use of heparin and carbohydrates to treat cancer |
US10639413B2 (en) | 2013-06-24 | 2020-05-05 | Exthera Medical Corporation | Blood filtration system containing mannose coated substrate |
US11306346B2 (en) | 2013-11-08 | 2022-04-19 | Exthera Medical Corporation | Methods for diagnosing infectious diseases using adsorption media |
US11844895B2 (en) | 2014-04-24 | 2023-12-19 | Exthera Medical Corporation | Method for removing bacteria from blood using high flow rate |
US10842818B2 (en) | 2014-07-23 | 2020-11-24 | Cerus Corporation | Methods for preparing platelet products |
WO2016014854A1 (en) | 2014-07-23 | 2016-01-28 | Cerus Corporation | Methods for preparing platelet products |
US10857283B2 (en) | 2014-09-22 | 2020-12-08 | Exthera Medical Corporation | Wearable hemoperfusion device |
WO2016057965A1 (en) | 2014-10-10 | 2016-04-14 | Cerus Corporation | Compositions and methods for treating viral hemorrhagic fever |
WO2016210374A1 (en) | 2015-06-26 | 2016-12-29 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
EP4410318A2 (en) | 2015-06-26 | 2024-08-07 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
US11096963B2 (en) | 2015-06-26 | 2021-08-24 | Cerus Corporation | Cryoprecipitate compositions and methods of preparation thereof |
US10799533B2 (en) | 2015-10-23 | 2020-10-13 | Cerus Corporation | Plasma compositions and methods of use thereof |
WO2017070619A1 (en) | 2015-10-23 | 2017-04-27 | Cerus Corporation | Plasma compositions and methods of use thereof |
WO2017120545A2 (en) | 2016-01-07 | 2017-07-13 | Cerus Corporation | Systems and methods for preparation of platelets |
US10786615B2 (en) | 2016-03-02 | 2020-09-29 | Exthera Medical Corporation | Method for treating drug intoxication |
US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
WO2018161020A1 (en) | 2017-03-03 | 2018-09-07 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
US11235090B2 (en) | 2017-03-03 | 2022-02-01 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
US12064537B2 (en) | 2017-03-03 | 2024-08-20 | Cerus Corporation | Kits and methods for preparing pathogen-inactivated platelet compositions |
WO2019060610A1 (en) | 2017-09-20 | 2019-03-28 | Cerus Corporation | Compositions and methods for pathogen inactivation of platelets |
US11499016B2 (en) | 2017-10-05 | 2022-11-15 | Fresenius Medical Care Holdings, Inc. | Polysulfone-urethane copolymer, membranes and products incorporating same, and methods for making and using same |
US10822461B2 (en) | 2017-10-05 | 2020-11-03 | Fresenius Medical Care Holdings, Inc. | Polysulfone-urethane copolymer, membranes and products incorporating same, and methods for making and using same |
US11554185B2 (en) | 2017-12-29 | 2023-01-17 | Cerus Corporation | Systems and methods for treating biological fluids |
WO2019133929A1 (en) | 2017-12-29 | 2019-07-04 | Cerus Corporation | Systems and methods for treating biological fluids |
WO2020061537A1 (en) | 2018-09-20 | 2020-03-26 | Cerus Corporation | Methods and kits for preparing pathogen-inactivated whole blood |
US12090261B2 (en) | 2019-05-16 | 2024-09-17 | Exthera Medical Corporation | Method for modulating endothelial glycocalyx structure |
US12011510B2 (en) | 2019-06-22 | 2024-06-18 | Cerus Corporation | Biological fluid treatment systems |
US11883544B2 (en) | 2019-06-28 | 2024-01-30 | Cerus Corporation | System and methods for implementing a biological fluid treatment device |
Also Published As
Publication number | Publication date |
---|---|
EP1487559A4 (en) | 2008-12-24 |
CA2477946A1 (en) | 2003-09-25 |
AU2003213758A1 (en) | 2003-09-29 |
EP1487559A1 (en) | 2004-12-22 |
JP2005519744A (en) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003078023A1 (en) | Compound removal device | |
US4728432A (en) | Method for decontaminating blood | |
KR100743483B1 (en) | Virus-removing bag and virus-removing method using the same | |
EP0586268B1 (en) | A pathogenic substance removing material and a blood filter comprising said material | |
JP5859558B2 (en) | Erythrocyte irradiation and anaerobic preservation | |
US20100222702A1 (en) | Method of using a packaging material for a medical instrument set | |
US5858641A (en) | Disinfectant dye removal from blood and blood fractions using a porous poly(vinyl alcohol-acetal) copolymer | |
JPS6314993B2 (en) | ||
JPS59139936A (en) | Immunoglobulin g adsorbent | |
JP2568846B2 (en) | Myoglobin adsorbent | |
WO2000003751A1 (en) | Disinfectant dye removal | |
JPH0611324B2 (en) | Porous hollow fiber membrane | |
JPS6362220B2 (en) | ||
EP0345943B1 (en) | Device for plasma modification composition and remodeling | |
JPS5979854A (en) | Method and apparatus for purifying serum | |
JP4533706B2 (en) | Filtration method and system | |
Maini et al. | Hepatic Support System Utilising High-Porosity Protein-Permeable Membranes in Conjunction with Dialysate Regeneration | |
AU2023226844A1 (en) | Pouch system for treating a biological fluid by electromagnetic irradiation | |
AU2023226843A1 (en) | Pouch system for treatment of a biological fluid by electromagnetic irradiation | |
NAKAJI et al. | Therapeutic Plasmapheresis (XII), pp. 211-214 T. Agishi et al.(Eds)© VSP 1993 | |
JP3028760U (en) | Blood processor packaging bag | |
CZ2012513A3 (en) | Method of removing platinum compounds and metabolites thereof from urine of patients treated with cytostatics and apparatus for making the same | |
JPH09220281A (en) | Sterilizing method for body fluid treating device and sterilized body fluid treating device | |
Nosé et al. | Sorbents in therapeutic medicine | |
JPS6359340B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2477946 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003213758 Country of ref document: AU Ref document number: 2003576074 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003711447 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003711447 Country of ref document: EP |